| SC 13G | 2018-02-08 | VANGUARD GROUP INC | GLAUKOS Corp | 2,388,105 | 6.9% | EDGAR |
| SC 13G | 2018-02-01 | BlackRock Inc. | GLAUKOS Corp | 1,957,114 | 5.7% | EDGAR |
| SC 13G | 2017-11-13 | JANUS HENDERSON GROUP PLC | GLAUKOS Corp | 4,068,125 | 11.8% | EDGAR |
| SC 13G | 2017-09-25 | Flynn James E | GLAUKOS Corp | 2,527,032 | 7.3% | EDGAR |
| SC 13G/A | 2017-02-14 | Frazier Healthcare V, LP | GLAUKOS Corp | - | - | EDGAR |
| SC 13G/A | 2017-02-14 | VERSANT VENTURE CAPITAL I LP | GLAUKOS Corp | 65,714 | 0.2% | EDGAR |
| SC 13G/A | 2017-02-14 | Meritech Capital Partners III LP | GLAUKOS Corp | 2,061,059 | 6.1% | EDGAR |
| SC 13G/A | 2017-02-14 | InterWest Partners IX, LP | GLAUKOS Corp | 1,018,362 | 3.0% | EDGAR |
| SC 13G | 2017-02-14 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | GLAUKOS Corp | 1,959,774 | 5.8% | EDGAR |
| SC 13G/A | 2017-02-13 | Burns Thomas William | GLAUKOS Corp | 2,347,537 | 6.9% | EDGAR |
| SC 13G/A | 2017-02-13 | ORBIMED ADVISORS LLC | GLAUKOS Corp | 2,159,430 | 6.4% | EDGAR |
| SC 13G | 2017-02-13 | Capital World Investors | GLAUKOS Corp | 1,945,000 | 5.7% | EDGAR |
| SC 13G/A | 2017-01-31 | MONTREUX EQUITY PARTNERS IV LP | GLAUKOS Corp | 0 | 0.0% | EDGAR |
| SC 13G | 2016-02-22 | MONTREUX EQUITY PARTNERS IV LP | GLAUKOS Corp | 3,118,406 | 9.7% | EDGAR |
| SC 13G | 2016-02-16 | Burns Thomas William | GLAUKOS Corp | 2,854,056 | 8.4% | EDGAR |
| SC 13G | 2016-02-16 | Meritech Capital Partners III LP | GLAUKOS Corp | 2,972,501 | 9.2% | EDGAR |
| SC 13G | 2016-02-16 | Frazier Healthcare V, LP | GLAUKOS Corp | 2,603,362 | 8.1% | EDGAR |
| SC 13G | 2016-02-12 | ORBIMED ADVISORS LLC | GLAUKOS Corp | 2,870,593 | 8.9% | EDGAR |
| SC 13G | 2016-02-12 | InterWest Partners IX, LP | GLAUKOS Corp | 2,603,362 | 8.1% | EDGAR |
| SC 13G | 2016-02-10 | VERSANT VENTURE CAPITAL I LP | GLAUKOS Corp | 2,884,836 | 9.0% | EDGAR |